熱門資訊> 正文

DXC Technology定价6.5亿欧元高级票据

2025-12-03 06:16

DXC Technology(DXC) 0
Crescent Biopharma(CBIO) 0

DXC Technology (NYSE:DXC) announced on Tuesday that its wholly owned subsidiary, DXC Capital Funding DAC, priced an offering of €650M of its 4.250% senior notes due 2030.
The offering will be priced at 99.784% of the aggregate principal amount of such notes.
The offering of the notes is expected to close on December 9, 2025, subject to customary conditions.
The company intends to apply the net proceeds from the offering to repay its existing debt, including the company's 1.750% senior notes due 2026, and for working capital and general corporate purposes.

More on DXC Technology Company

DXC Technology Company (DXC) Presents at J.P. Morgan 2025 Ultimate Services Investor Conference Transcript
The Bottom Fishing Club - DXC Technology: Exceptional FCF Yield And AI Catalysts
DXC Technology Company 2026 Q2 - Results - Earnings Call Presentation
DXC targets doubling SAP and SaaS revenue over next 2-3 years while advancing AI-driven fast track solutions
DXC Technology Company Non-GAAP EPS of $0.84 beats by $0.14, revenue of $3.16B misses by $10M

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。